| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97bfe42c8a154a8a16b67823210f7e89 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447ad71b5c1b32daa02d10b641a1f381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82ec935d93b78746143b3c9a5aea285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3efbd4d531d87dddd188a891b17aa7 |
| publicationDate |
2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1750701-A1 |
| titleOfInvention |
Amorphous clopidogrel hydrochloride and its antithrombotic use |
| abstract |
The invention provides methyl (+)-(S)-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate hydrochloride in amorphous form, processes for the preparation of the amorphous form and a pharmaceutical composition containing the amorphous form. The amorphous form is useful as a blood platelet aggregation inhibitor and as an antithrombotic agent. |
| priorityDate |
2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |